NPCT Nuveen quarterly earnings details remain undisclosed investors await updates on its impact fund portfolio performance Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia Impact BioMedical IBO CEO lays out novel drug pipeline priorities to drive longterm global market expansion